Innovations for Pharma New Series of Robots for Flexibility and Precision
Stäubli Robotics will be launching its new series of robots – Stericlean+ at an upcoming pharma event in 2022. The robots are designed exclusively for use in isolators and deliver high flexibility and precision.
Stäubli Robotics worked in close partnership with OEMs and integrators to expand its robotics portfolio for pharmaceutical applications. As a result, Stericlean+ meets all of the market’s requirements today and can help manufacturers future-proof their production for tomorrow, adds the firm.
The new range includes three six-axis robot models featuring a new pharma-approved coating on the complete robot body, new hygienic-design covers, and new pharma-approved joint sealing on each axis. All three models are fully tested and validated by Stäubli partner Skan, a specialist in process isolators for aseptic filling.
At the event, the company will showcase the flagship Stericlean+ TX2-60 robot for the first time within a new isolator cell. This model features a unique fully hygienic design with an optional hollow wrist and aseptic tool changer. The hollow wrist assures absolute hygienic design. The tool changer, developed in partnership with the Stäubli Connectors division, enhances the flexibility and usage of the robot, enabling quick process changes under sterile conditions, mentions the firm.
The robot will perform each step in a standard filling application, demonstrating its ability to reliably handle a series of auxiliary tasks, including picking containers, filling them, weighing and capping them with high repeatability, accuracy and output – and absolutely no human intervention, eliminating the risk of contamination, opines the company.
Stäubli will also demonstrate robotic telemanipulation with its Swiss partner Force Dimension, which specializes in force feedback-based haptic devices. Attendees will have the opportunity to use these devices to touch, feel and manipulate vials in a virtual environment.
The new Stericlean+ robot will bring even more advanced capabilities for a range of clinical and commercial applications, including:
- API and biotherapy production
- Cell and gene therapy (CGT) development
- Biologic and cytotoxic drug processing and compounding
- Auxiliary processes, i.e. loading/unloading, component feeding, inspections
- Filling and closing of vials, syringes, bags and cartridges
- Primary and secondary packaging
Whether in a small isolator with a single robot capable of handling several independent or linked operations, or in a complete production line equipped with multiple robots, the new range allows processing of different RTU containers, easily accommodating changes in production for optimal flexibility in aseptic pharmaceutical manufacturing.